Form D Explorer

Inspect source fieldsReport a record issue

Form D — ABLi Therapeutics, Inc.

0002104142-26-000001 · filed Jan 13, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$1,000,000
Reported amount sold
$1,000,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
ABLi Therapeutics, Inc.
CIK
2104142
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2025
Address
3350 RIVERWOOD PKWY SE
ATLANTA, Georgia 30339
Phone
917-494-0831

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗